JAK2 617V>F-positive polycythemia rubra vera maintained by approximately 18 stochastic stem-cell divisions per year, explaining age of onset by a single rate-limiting mutation

被引:7
作者
Vickers, Mark A. [1 ]
机构
[1] Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
关键词
D O I
10.1182/blood-2006-12-061911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As the rates of most cancers are proportional to the fourth to fifth power of age ("log-log" behavior), it is widely believed that 5 to 6 independent mutations are necessary for malignant transformation. Conversely, the peak incidences of most cancers are similar to stem-cell mutation rates at single loci, implying only one rate-limiting mutation. Here, flow cytometrically measured red blood cells mutated at a selectively neutral locus, glycophorin A, allow observation of individual stem-cell differentiation events in a log-log malignancy, polycythemia rubra vera. Contrary to predictions from multistep models, the clone is driven by infrequent (< annual) and rare (similar to 18 per year) differentiation events. These parameters imply that malignant stem cells have a modest selective advantage. Correspondingly minor, typically less than 20%, increases in stochastic self-renewal ratios are modeled to show that single mutations can result in the observed fourth power relationship with age. The conundrum between log-log behavior and mutation rate is thereby reconcilable, with the age of onset arising not from the requirement for multiple, independent mutations but from infrequent, stochastic stem-cell division rates and single mutations causing initially minor effects, but initiating a clone whose expected number increases successively with age-an "exponential phenotype".
引用
收藏
页码:1675 / 1680
页数:6
相关论文
共 40 条
[1]   Evidence that hematopoiesis may be a stochastic process in vivo [J].
Abkowitz, JL ;
Catlin, SN ;
Guttorp, P .
NATURE MEDICINE, 1996, 2 (02) :190-197
[2]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]   THE AGE DISTRIBUTION OF CANCER AND A MULTI-STAGE THEORY OF CARCINOGENESIS [J].
ARMITAGE, P ;
DOLL, R .
BRITISH JOURNAL OF CANCER, 1954, 8 (01) :1-12
[4]   A 2-STAGE THEORY OF CARCINOGENESIS IN RELATION TO THE AGE DISTRIBUTION OF HUMAN CANCER [J].
ARMITAGE, P ;
DOLL, R .
BRITISH JOURNAL OF CANCER, 1957, 11 (02) :161-169
[5]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[6]   Mutator phenotype in cancer: Timing and perspectives [J].
Bielas, JH ;
Loeb, LA .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2005, 45 (2-3) :206-213
[7]   Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[8]   Mutation of JAK2 in the myeloproliferative disorders:: timing, clonality studies, cytogenetic associations, and role in leukemic transformation [J].
Campbell, Peter J. ;
Baxter, E. Joanna ;
Beer, Philip A. ;
Scott, Linda M. ;
Bench, Anthony J. ;
Huntly, Brian J. P. ;
Erber, Wendy N. ;
Kusec, Rajko ;
Larsen, Thomas Stauffer ;
Giraudier, Stephane ;
Le Bousse-Kerdiles, Marie-Caroline ;
Griesshammer, Martin ;
Reilly, John T. ;
Cheung, Betty Y. ;
Harrison, Claire N. ;
Green, Anthony R. .
BLOOD, 2006, 108 (10) :3548-3555
[9]  
CARTWRIGHT RA, 1997, DESCRIPTIVE EPIDEMIO, P37
[10]   The kinetics of clonal dominance in myeloproliferative disorders [J].
Catlin, SN ;
Guttorp, P ;
Abkowitz, JL .
BLOOD, 2005, 106 (08) :2688-2692